ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 55 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,356 | -99.8% | 400,000 | 0.0% | 0.13% | +140.0% |
| Q3 2022 | $1,280,000 | -28.6% | 400,000 | 0.0% | 0.06% | -42.7% |
| Q2 2022 | $1,792,000 | -16.1% | 400,000 | 0.0% | 0.10% | +7.9% |
| Q1 2022 | $2,136,000 | -63.7% | 400,000 | 0.0% | 0.09% | -44.4% |
| Q4 2021 | $5,880,000 | -29.7% | 400,000 | 0.0% | 0.16% | -14.4% |
| Q3 2021 | $8,364,000 | +18.2% | 400,000 | 0.0% | 0.19% | +29.9% |
| Q2 2021 | $7,076,000 | +188.8% | 400,000 | +300.0% | 0.14% | +234.9% |
| Q1 2021 | $2,450,000 | -27.6% | 100,000 | 0.0% | 0.04% | -41.1% |
| Q4 2020 | $3,385,000 | -5.0% | 100,000 | -29.8% | 0.07% | -16.1% |
| Q3 2020 | $3,564,000 | -29.6% | 142,500 | -5.0% | 0.09% | -38.7% |
| Q2 2020 | $5,060,000 | – | 150,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |